Baxter International Inc. (BAX)
NYSE: BAX
· Real-Time Price · USD
30.63
-0.54 (-1.73%)
At close: May 01, 2025, 3:59 PM
30.23
-1.31%
After-hours: May 01, 2025, 07:37 PM EDT
Baxter International Revenue Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|
| Medical Products And Therapies Revenue | 569M | 272M | 263M | 796M | 255M |
| Medical Products And Therapies Revenue Growth | +109.19% | +3.42% | -66.96% | +212.16% | n/a |
| Healthcare Systems and Technologies Revenue | 576M | 296M | 265M | 912M | 301M |
| Healthcare Systems and Technologies Revenue Growth | +94.59% | +11.70% | -70.94% | +202.99% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emea Revenue | 1.35B | 3.32B | 3.71B | 3.55B | 3.13B | 2.97B | 2.96B | 2.73B | 2.7B | 2.77B | 5.14B | 4.6B | 6.06B | 4.39B | 4.19B |
| Emea Revenue Growth | -59.33% | -10.51% | +4.42% | +13.52% | +5.42% | +0.24% | +8.42% | +1.26% | -2.78% | -45.99% | +11.73% | -24.09% | +37.89% | +4.87% | n/a |
| United States Revenue | 5.85B | 7B | 7.22B | 5.18B | 4.88B | 4.83B | 4.72B | 4.51B | 4.26B | 4B | 7.01B | 6.45B | n/a | 5.71B | 5.26B |
| United States Revenue Growth | -16.43% | -3.09% | +39.44% | +6.19% | +1.08% | +2.18% | +4.72% | +5.89% | +6.45% | -42.97% | +8.74% | n/a | n/a | +8.45% | n/a |
| Western Europe, Canada, Japan, Australia And New Zealand Revenue | 3.44B | 4.49B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Western Europe, Canada, Japan, Australia And New Zealand Revenue Growth | -23.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 754M | 1.02B | 857M | 935M | 1B | 964M | 1.01B | 912M | 942M | 976M | 1.05B | 885M | 680M | 678M | 627M | 650M | 601M | 590M | 628M | 1.42B | 627M | 642M | 600M | 629M | 685M | 681M | 622M | 697M | 685M | 635M | 570M | 663M | 726M | 709M | 641M | 733M | 794M | 1.1B | 1.01B |
| Selling, General, and Administrative Revenue Growth | -26.15% | +19.14% | -8.34% | -6.69% | +3.94% | -4.55% | +10.75% | -3.18% | -3.48% | -7.22% | +18.87% | +30.15% | +0.29% | +8.13% | -3.54% | +8.15% | +1.86% | -6.05% | -55.81% | +126.63% | -2.34% | +7.00% | -4.61% | -8.18% | +0.59% | +9.49% | -10.76% | +1.75% | +7.87% | +11.40% | -14.03% | -8.68% | +2.40% | +10.61% | -12.55% | -7.68% | -27.62% | +8.08% | n/a |
| Research and Development Revenue | 129M | 173M | 160M | 172M | 166M | 165M | 164M | 155M | 152M | 148M | 150M | 138M | 129M | 139M | 128M | 135M | 123M | 117M | 146M | 156M | 144M | 166M | 129M | 175M | 166M | 174M | 140M | 182M | 151M | 156M | 128M | 157M | 159M | 195M | 136M | 161M | 148M | 388M | 300M |
| Research and Development Revenue Growth | -25.43% | +8.12% | -6.98% | +3.61% | +0.61% | +0.61% | +5.81% | +1.97% | +2.70% | -1.33% | +8.70% | +6.98% | -7.19% | +8.59% | -5.19% | +9.76% | +5.13% | -19.86% | -6.41% | +8.33% | -13.25% | +28.68% | -26.29% | +5.42% | -4.60% | +24.29% | -23.08% | +20.53% | -3.21% | +21.88% | -18.47% | -1.26% | -18.46% | +43.38% | -15.53% | +8.78% | -61.86% | +29.33% | n/a |